TY - JOUR
T1 - Inducible capillary formation in lymphatic endothelial cells by blocking lipid phosphate phosphatase-3 activity
AU - Senda, Kazutaka
AU - Koizumi, Keiichi
AU - Prangsaengtong, Orawin
AU - Minami, Takayuki
AU - Suzuki, Shunsuke
AU - Takasaki, Ichiro
AU - Tabuchi, Yoshiaki
AU - Sakurai, Hiroaki
AU - Doki, Yoshinori
AU - Misaki, Takuro
AU - Saiki, Ikuo
PY - 2009/6/1
Y1 - 2009/6/1
N2 - Lymphangiogenesis plays critical roles under normal and/or pathological conditions; however, the molecular contributors to this event were unknown until recently. In the present study, we first employed gene chip analysis and confirmed that lipid phosphate phosphatase-3 (LPP3) expression was increased until capillary formation in the conditionally immortalized rat lymphatic endothelial cell line. Signaling responses occur when several lipids induce acute biological functions; further, lipid phosphate phosphatases (LPPs) control their functions via dephosphorylation; however, there is no report on the association between LPP3 and lymphangiogenesis. siRNA-targeted LPP3 significantly increased capillary formation of human lymphatic endothelial cells; in contrast, it decreased cell adhesion to the basement membrane matrix. Furthermore, the inducible effect of the LPP inhibitor on capillary formation was observed. For the first time, we report that LPP3 abolishes accelerated abnormal lymphangiogenesis. Blocking LPP3 activities may aid in the development of novel therapy for lymph vessel defects.
AB - Lymphangiogenesis plays critical roles under normal and/or pathological conditions; however, the molecular contributors to this event were unknown until recently. In the present study, we first employed gene chip analysis and confirmed that lipid phosphate phosphatase-3 (LPP3) expression was increased until capillary formation in the conditionally immortalized rat lymphatic endothelial cell line. Signaling responses occur when several lipids induce acute biological functions; further, lipid phosphate phosphatases (LPPs) control their functions via dephosphorylation; however, there is no report on the association between LPP3 and lymphangiogenesis. siRNA-targeted LPP3 significantly increased capillary formation of human lymphatic endothelial cells; in contrast, it decreased cell adhesion to the basement membrane matrix. Furthermore, the inducible effect of the LPP inhibitor on capillary formation was observed. For the first time, we report that LPP3 abolishes accelerated abnormal lymphangiogenesis. Blocking LPP3 activities may aid in the development of novel therapy for lymph vessel defects.
UR - http://www.scopus.com/inward/record.url?scp=67650848380&partnerID=8YFLogxK
U2 - 10.1089/lrb.2009.0005
DO - 10.1089/lrb.2009.0005
M3 - 学術論文
C2 - 19473074
AN - SCOPUS:67650848380
SN - 1539-6851
VL - 7
SP - 69
EP - 74
JO - Lymphatic Research and Biology
JF - Lymphatic Research and Biology
IS - 2
ER -